FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

385224003: Powder for conventional release suspension for injection (dose form)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Jun 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1459403017 Powder for injection suspension (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
1479481018 Powder for injection suspension en Synonym Inactive Entire term case insensitive SNOMED CT core module
2647451016 Powder for suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module
2660098010 Powder for injection suspension (qualifier value) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3620910017 Powder for conventional release suspension for injection (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3620911018 Powder for conventional release suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module
46814601000001116 Powder and solvent for suspension for injection en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom Edition module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Powder for conventional release suspension for injection Is a Type of drug preparation false Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Is a Drug powder false Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Is a Powder for reconstitution for drug product false Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Is a Injection false Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Is a Injection powder false Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Is a Parenteral dose form true Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Has dose form administration method Inject true Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Has dose form transformation Disperse true Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Powder for conventional release suspension for injection Has basic dose form Powder true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Extencilline 600,000units powder and solvent for suspension for injection vials (Aventis Laboratories) 50 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Extencilline 1.2million unit powder and solvent for suspension for injection vials (Aventis Laboratories) 50 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Extencilline 2.4million unit powder and solvent for suspension for injection vials (Aventis Laboratories) 50 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Retarpen 2.4million unit powder and solvent for suspension for injection vials (Biochemie GmbH) 50 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for injection suspension vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
M-M-RVAXPRO vaccine powder and solvent for suspension for injection 0.5ml pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Measles, Mumps and Rubella vaccine (live) powder and solvent for suspension for injection 0.5ml pre-filled syringes 1 pre-filled disposable injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
M-M-RVAXPRO vaccine powder and solvent for suspension for injection 0.5ml pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) 1 pre-filled disposable injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) 1 vial Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely paclitaxel 100 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has dispensed dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials Has manufactured dose form False Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has manufactured dose form True Powder for conventional release suspension for injection Inferred relationship Existential restriction modifier

Start Previous Page 3 of 3

This concept is not in any reference sets

Back to Start